NATCO PHARMA LTD. - 524816 - Financial Results For The Quarter And Half Year Ended 30Th September, 2023
Financial Results for the quarter and half year ended 30th September, 202314-11-2023
14-11-2023
NATCO PHARMA LTD. - 524816 - Board Meeting Outcome for Outcome Of The Board Meeting
Outcome of the Board Meeting14-11-2023
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Q2FY24 Financial Results Earnings Call09-11-2023
NATCO PHARMA LTD. - 524816 - Board Meeting Intimation for The Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2023 And Declaration Of Second Interim Dividend, If Any
NATCO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2023 ,inter alia, to consider and approve The Unaudited Financial Results for the quarter and half year ended 30th September 2023 and declaration of second interim dividend, if any03-11-2023
Natco Pharma gains 3% on USFDA all-clear
The share touched a 52-week high of Rs 928.45 on September 7, 2023 and a 52-week low of Rs 502 on February 2, 2023.02-11-2023
NATCO PHARMA LTD. - 524816 - Successful Completion Of United States Food And Drug Administration'S (USFDA) Inspection
Successful completion of United States Food and Drug Administration''s (USFDA) inspection02-11-2023
Natco Pharma shares down as USFDA issues 8 observations for Hyderabad unit
The company is confident of addressing all the observations within the stipulated time and is working with the USFDA to close them at the earliest.20-10-2023
NATCO PHARMA LTD. - 524816 - Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015
Intimation under Regulation 30 of SEBI (LODR) Regulations, 201519-10-2023
NATCO PHARMA LTD. - 524816 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate for the Quarter ended September 30, 202306-10-2023
NATCO PHARMA LTD. - 524816 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
E-voting Results for the 40th Annual General Meeting held on 29th September 202329-09-2023